Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. (Q51478110)
Jump to navigation
Jump to search
scientific article published in March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. |
scientific article published in March 2007 |
Statements
1 reference
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. (English)
1 reference
M A Nauck
1 reference
G Meininger
1 reference
D Sheng
1 reference
L Terranella
1 reference
P P Stein
1 reference
Sitagliptin Study 024 Group
1 reference
1 March 2007
1 reference
9
1 reference
194-205
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference